news
CYC065-eribulin combination for triple-negative breast cancer identified
Researchers find novel combination disrupts multiple factors in aggressive breast cancer...
List view / Grid view
Drug Targets
news
Prostaglandin EI inhibits leukaemia stem cells
Targeting leukaemia stem cells in combination with standard chemotherapy may improve treatment for chronic myeloid leukaemia...
news
UCB receives EU approval for paediatric anti-epileptic drug
UCB has announced that the EC has approved the use of its anti-epileptic drug Vimpatas in the treatment of partial-onset seizures...
news
Beta-blocker therapy after heart attack questioned
Researchers have found that beta blockers are not needed after a heart attack if survivors are taking ACE inhibitors and statins...
news
Nivolumab superior to ipilimumab for adjuvant treatment of melanoma
Adjuvant nivolumab has been found to be more superior than ipilimumab in the standard of care in patients with surgically resected stage III/IV melanoma...
news
Taselisib boosts breast tumour shrinkage
According to results of the LORELEI clinical trial, adding taselisib to letrozole before surgery significantly improved outcomes for patients with early breast cancer...
news
Pembrolizumab shows promise in pretreated metastatic gastric cancer
Pembrolizumab has shown a promising response rate in patients with pre-treated metastatic gastric cancer, according to results from the KEYNOTE-059 trial...
news
Asthma medicine halves risk of Parkinson’s
Researchers have found that asthma medicine can halve a patient's risk of developing Parkinson's disease...
news
Beta blockers have positive effect in pulmonary arterial hypertension
A team of researchers have found that a common heart disease medication may help treat lung disease...
news
FDA approves CAR T cell therapy for children with leukaemia
The FDA has approved CAR T cell therapy for treatment of children with acute lymphoblastic leukemia...
news
Z-endoxifen shows promise for breast cancer
Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer...
news
Immunotherapy combination effective at killing cancer cells
Researchers have recently discovered an immunotherapy that uses existing cancer drugs in a whole new way...
news
Anacetrapib reduces risk of serious cardiovascular events
An international clinical trial has assessed the efficacy and safety of adding anacetrapib versus placebo atorvastatin in patients with vascular diseases...
news
Combination of conventional drugs enhances tumour cell death
Brazilian researchers have investigated whether cisplatin and 5-FU would interfere with the protein pRB...
news
Cancer drug can reactivate HIV
A team of scientists have recently discovered how a new drug called JQ1 which is currently in early-phase human cancer trials, can reactivate latent HIV...
